12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

3M TEGADERM SILVER (AG) MESH

FDA 510(k)
FDA Unclassified ·Unknown

BI-3M NEEDLE-FREE INJECTOR SYSTEM

FDA 510(k)
FDA Class 2 ·General Hospital

PCCR DIGITAL IMAGING DEVICE

FDA 510(k)
FDA Class 2 ·Radiology

TRULIANT TIB IMP PS INSERT SZ 4 9MM

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code JWH·January 29, 2025

BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM

FDA Adverse Event
Malfunction ·BD (SUZHOU)·Product code FOZ·August 31, 2023

TENSION FREE VAGINAL TAPE

FDA Adverse Event
Injury ·ETHICON, INC.·Product code OTN·April 11, 2013

UNIVERSAL DRIVER

FDA Adverse Event
Malfunction ·ABBOTT SPINE, INC.·Product code HXX·May 28, 2008

SIGMA 300 DR

FDA Adverse Event
Injury ·MEDTRONIC S.A.·Product code DXY·April 13, 2011

BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM

FDA Adverse Event
Malfunction ·BD (SUZHOU)·Product code FOZ·August 31, 2022

UNKNOWN BIOLOX DELTA 32MM -4MM HEAD

FDA Adverse Event
Injury ·ZIMMER GMBH·Product code LZO·March 31, 2025

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

Aespire View. This anesthesia gas machine is intended to provide general inhalation anesthesia and ventilatory support to patients and are to be used only by medical professionals trained and qualified in the administration of general anesthesia.

FDA Enforcement
Class I ·Ongoing·Datex-Ohmeda, Inc.·October 30, 2024